Eventide Asset Management - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$38,397,000
-14.9%
578,0000.0%0.51%
-16.5%
Q2 2021$45,096,000
-5.6%
578,000
+14.5%
0.61%
-14.4%
Q1 2021$47,768,000
-32.8%
505,000
-13.4%
0.71%
-35.0%
Q4 2020$71,039,000
+112.3%
583,000
+52.2%
1.09%
+66.3%
Q3 2020$33,459,000
+35.3%
383,0000.0%0.66%
+21.7%
Q2 2020$24,738,000383,0000.54%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q1 2021.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders